Centre CAP is a private CRO conducting Phase I and II studies in the following fields :

• - first-in-man administration
• - safety and tolerability of a drug (with an experienced in-house staff specially trained for intraveinous administration)
• - drug interactions
• - food intake effects
• - pharmacokinetics of a same product with different formulas and/or doses
• - prolongation of the QTc interval
• - identification of biomarkers
• - vaccination studies
• - bioavailibility and bioequivalence studies
• - tolerability studies
• - proof of concept studies
• - pharmacokinetics / pharmacodynamics studies